Supplementary Figure S2 from Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis

Li Gu,Yahui Zhu,Xi Lin,Yajun Li,Kaisa Cui,Edward V. Prochownik,Youjun Li

DOI: https://doi.org/10.1158/0008-5472.22420244.v1

2023-01-01

Abstract:Supplementary Figure S2 shows that GNPAT interacts with DRP1 to regulate mitochondrial morphology.

What problem does this paper attempt to address?

Supplementary Figure S5 from Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis

Li Gu,Yahui Zhu,Xi Lin,Yajun Li,Kaisa Cui,Edward V. Prochownik,Youjun Li

DOI: https://doi.org/10.1158/0008-5472.22420235.v1

2023-01-01

Abstract:Supplementary Figure S5 shows that DRP1 mediates GNPAT's oncogenic phenotypes.
Supplementary Figure S3 from Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis

Li Gu,Yahui Zhu,Xi Lin,Yajun Li,Kaisa Cui,Edward V. Prochownik,Youjun Li

DOI: https://doi.org/10.1158/0008-5472.22420241

2023-01-01

Abstract:Supplementary Figure S3 presents the data of GNPAT recruiting USP30 to deubiquitinate and stabilize DRP1.
Supplementary Figure S1 from Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis

Li Gu,Yahui Zhu,Xi Lin,Yajun Li,Kaisa Cui,Edward V. Prochownik,Youjun Li

DOI: https://doi.org/10.1158/0008-5472.22420247.v1

2023-01-01

Abstract:Supplementary Figure S1 illustrates that GNPAT is amplified and upregulated in HCCs.
Supplementary Figure S7 from Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis

Li Gu,Yahui Zhu,Xi Lin,Yajun Li,Kaisa Cui,Edward V. Prochownik,Youjun Li

DOI: https://doi.org/10.1158/0008-5472.22420229.v1

2023-01-01

Abstract:Supplementary Figure S7 shows that GNPAT expression in HCC cells without GNPAT amplification is transcriptionally regulated by the complex composed of Myc and KDM1A.
Supplementary Figure S4 from Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis

Li Gu,Yahui Zhu,Xi Lin,Yajun Li,Kaisa Cui,Edward V. Prochownik,Youjun Li

DOI: https://doi.org/10.1158/0008-5472.22420238.v1

2023-01-01

Abstract:Supplementary Figure S4 shows that knockout GNPAT or DRP1 retards tumor growth using CRISPR/Cas9 technology.
Data from Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis

Li Gu,Yahui Zhu,Xi Lin,Yajun Li,Kaisa Cui,Edward V. Prochownik,Youjun Li

DOI: https://doi.org/10.1158/0008-5472.c.6510599

2023-01-01

Abstract:AbstractHepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and the underlying pathophysiology of HCC is highly complex. In this study, we report that, in a bioinformatic screen of 2,783 genes encoding metabolic enzymes, GNPAT, which encodes the enzyme glyceronephosphate O-acyltransferase, is amplified, upregulated, and highly correlated with poor clinical outcome in human patients with HCC. High GNPAT expression in HCC was due to its amplification and transcriptional activation by the c-Myc/KDM1A complex. GNPAT compensated the oncogenic phenotypes in c-Myc–depleted HCC cells. Mechanistically, GNPAT recruited the enzyme USP30, which deubiquitylated and stabilized dynamin-related protein 1 (DRP1), thereby facilitating regulation of mitochondrial morphology, lipid metabolism, and hepatocarcinogenesis. Inhibition of GNPAT and DRP1 dramatically attenuated lipid metabolism and hepatocarcinogenesis. Furthermore, DRP1 mediated the oncogenic phenotypes driven by GNPAT. Taken together, these results indicate that GNPAT and USP30-mediated stabilization of DRP1 play a critical role in the development of HCC.Significance: This study identifies and establishes the role of the enzyme GNPAT in liver cancer progression, which may serve as a potential therapeutic target for liver cancer. Cancer Res; 78(20); 5808–19. ©2018 AACR.
Amplification of glyceronephosphate O-acyltransferase and recruitment of USP30 stabilize DRP1 to promote hepatocarcinogenesis.

Li Gu,Yahui Zhu,Xi Lin,Yajun Li,Kaisa Cui,Edward V Prochownik,Youjun Li

DOI: https://doi.org/10.1158/0008-5472.CAN-18-0340

IF: 11.2

2018-01-01

Cancer Research

Abstract:Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and the underlying pathophysiology of HCC is highly complex. In this study, we report that, in a bioinformatic screen of 2,783 genes encoding metabolic enzymes, GNPAT, which encodes the enzyme glyceronephosphate O-acyltransferase, is amplified, upregulated, and highly correlated with poor clinical outcome in human patients with HCC. High GNPAT expression in HCC was due to its amplification and transcriptional activation by the c-Myc/KDM1A complex. GNPAT compensated the oncogenic phenotypes in c-Myc-depleted HCC cells. Mechanistically, GNPAT recruited the enzyme USP30, which deubiquitylated and stabilized dynamin-related protein 1 (DRP1), thereby facilitating regulation of mitochondrial morphology, lipid metabolism, and hepatocarcinogenesis. Inhibition of GNPAT and DRP1 dramatically attenuated lipid metabolism and hepatocarcinogenesis. Furthermore, DRP1 mediated the oncogenic phenotypes driven by GNPAT. Taken together, these results indicate that GNPAT and USP30-mediated stabilization of DRP1 play a critical role in the development of HCC. Significance: This study identifies and establishes the role of the enzyme GNPAT in liver cancer progression, which may serve as a potential therapeutic target for liver cancer. (C) 2018 AACR.
O-GlcNAcylation Promotes Pancreatic Tumor Growth by Regulating Malate Dehydrogenase 1

Qiang Zhu,Hong Zhou,Liming Wu,Zhenyuan Lai,Didi Geng,Weiwei Yang,Jie Zhang,Zhiya Fan,Weijie Qin,Yong Wang,Ruhong Zhou,Wen Yi

DOI: https://doi.org/10.1038/s41589-022-01085-5

IF: 14.8

2022-01-01

Nature Chemical Biology

Abstract:Oncogenic Kras-activated pancreatic ductal adenocarcinoma (PDAC) cells highly rely on an unconventional glutamine catabolic pathway to sustain cell growth. However, little is known about how this pathway is regulated. Here we demonstrate that Kras mutation induces cellular O -linked β- N -acetylglucosamine ( O -GlcNAc), a prevalent form of protein glycosylation. Malate dehydrogenase 1 (MDH1), a key enzyme in the glutamine catabolic pathway, is positively regulated by O -GlcNAcylation on serine 189 (S189). Molecular dynamics simulations suggest that S189 glycosylation on monomeric MDH1 enhances the stability of the substrate-binding pocket and strengthens the substrate interactions by serving as a molecular glue. Depletion of O -GlcNAcylation reduces MDH1 activity, impairs glutamine metabolism, sensitizes PDAC cells to oxidative stress, decreases cell proliferation and inhibits tumor growth in nude mice. Furthermore, O -GlcNAcylation levels of MDH1 are elevated in clinical PDAC samples. Our study reveals that O -GlcNAcylation contributes to pancreatic cancer growth by regulating the metabolic activity of MDH1.
Stabilization of FASN by ACAT1-mediated GNPAT Acetylation Promotes Lipid Metabolism and Hepatocarcinogenesis

Li Gu,Yahui Zhu,Xi Lin,Xingyu Tan,Bingjun Lu,Youjun Li

DOI: https://doi.org/10.1038/s41388-020-1156-0

IF: 8.756

2020-01-01

Oncogene

Abstract:Metabolic alteration for adaptation of the local environment has been recognized as a hallmark of cancer. GNPAT dysregulation has been implicated in hepatocellular carcinoma (HCC). However, the precise posttranslational regulation of GNPAT is still undiscovered. Here we show that ACAT1 is upregulated in response to extra palmitic acid (PA). ACAT1 acetylates GNPAT at K128, which represses TRIM21-mediated GNPAT ubiquitination and degradation. Conversely, GNPAT deacetylation by SIRT4 antagonizes ACAT1's function. GNPAT represses TRIM21-mediated FASN degradation and promotes lipid metabolism. Furthermore, shRNA-mediated ACAT1 ablation and acetylation deficiency of GNPAT repress lipid metabolism and tumor progression in xenograft and DEN/CCl4-induced HCC. Otherwise, ACAT1 inhibitor combination with sorafenib enormously retards tumor formation in mice. Collectively, we demonstrate that stabilization of FASN by ACAT1-mediated GNPAT acetylation plays a critical role in hepatocarcinogenesis.
Regulation of mitochondrial fission by GIPC-mediated Drp1 retrograde transport

Aaron Ramonett,Eun-A Kwak,Tasmia Ahmed,Paola Cruz Flores,Hannah R. Ortiz,Yeon Sun Lee,Todd W. Vanderah,Tally Largent-Milnes,David F. Kashatus,Paul R. Langlais,Karthikeyan Mythreye,Nam Y. Lee

DOI: https://doi.org/10.1091/mbc.E21-06-0286

2021-10-28

Molecular Biology of the Cell

Abstract:Drp1 is a key regulator of mitochondrial fission, a large cytoplasmic GTPase recruited to the mitochondrial surface via transmembrane adaptors to initiate scission. While Brownian motion likely accounts for the local interactions between Drp1 and the mitochondrial adaptors, how this essential enzyme is targeted from more distal regions like the cell periphery remains unknown. Based on proteomic interactome screening and cell-based studies, we report that GIPC mediates the actin-based retrograde transport of Drp1 towards the perinuclear mitochondria to enhance fission. Drp1 interacts with GIPC through its atypical C-terminal PDZ-binding motif. Loss of this interaction abrogates Drp1 retrograde transport resulting in cytoplasmic mislocalization and reduced fission despite retaining normal intrinsic GTPase activity. Functionally, we demonstrate that GIPC potentiates the Drp1-driven proliferative and migratory capacity in cancer cells. Together, these findings establish a direct molecular link between altered GIPC expression and Drp1 function in cancer progression and metabolic disorders.

cell biology
Figure S7 from P38γ MAPK is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis

Fang Wang,Xiao-Mei Qi,Ryan Wertz,Matthew Mortensen,Catherine Hagen,John Evans,Yuri Sheinin,Michael James,Pengyuan Liu,Susan Tsai,James Thomas,Alexander Mackinnon,Michael Dwinell,Charles R. Myers,Ramon Bartrons Bach,Liwu Fu,Guan Chen

DOI: https://doi.org/10.1158/0008-5472.22423419.v1

2023-01-01

Abstract:Figure S7. PFD collaborates with PFK15 to inhibit glucose uptake, lactate secretion, and Pdac growth and upregulated p-PFKFB3 in Pdac specimens is positively correlated with overexpressed p38ÃƒÅ½Ã,Â³ and Glut2.
O-GlcNAcylation of G6PD Promotes the Pentose Phosphate Pathway and Tumor Growth

Xiongjian Rao,Xiaotao Duan,Weimin Mao,Xuexia Li,Zhonghua Li,Qian Li,Zhiguo Zheng,Haimiao Xu,Min Chen,Peng G. Wang,Yingjie Wang,Binghui Shen,Wen Yi

DOI: https://doi.org/10.1038/ncomms9468

IF: 16.6

2015-01-01

Nature Communications

Abstract:The pentose phosphate pathway (PPP) plays a critical role in macromolecule biosynthesis and maintaining cellular redox homoeostasis in rapidly proliferating cells. Upregulation of the PPP has been shown in several types of cancer. However, how the PPP is regulated to confer a selective growth advantage on cancer cells is not well understood. Here we show that glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme of the PPP, is dynamically modified with an O-linked β-N-acetylglucosamine sugar in response to hypoxia. Glycosylation activates G6PD activity and increases glucose flux through the PPP, thereby providing precursors for nucleotide and lipid biosynthesis, and reducing equivalents for antioxidant defense. Blocking glycosylation of G6PD reduces cancer cell proliferation in vitro and impairs tumor growth in vivo. Importantly, G6PD glycosylation is increased in human lung cancers. Our findings reveal a mechanistic understanding of how O-glycosylation directly regulates the PPP to confer a selective growth advantage to tumours.
GTPase-activating protein ARAP1 regulates circular dorsal ruffles as a nutrient uptake mechanism in the Hep3B hepatocellular carcinoma cell line

Xiaowei Sun,Yanan Li,Yuxin He,Longjiao Cheng,Jinzi Wei,Linxuan Du,Zhongyang Shen,Sei Yoshida

DOI: https://doi.org/10.1101/2023.12.31.573800

2024-01-02

Abstract:Circular dorsal ruffles (CDRs), large-scale rounded membrane ruffles, function as precursors of macropinocytosis. We recently reported that CDRs are exposed in the Hep3B hepatocellular carcinoma cell line, while not in other hepatocellular carcinoma cell lines, indicating that the CDRs in Hep3B are associated with malignant potential. In this study, we investigated the cellular function of CDRs in Hep3B cells by focusing on the molecular mechanisms of the GTPase-activating protein ARAP1. ARAP1 was localized to the CDRs, the sizes of which were reduced by deletion of this protein. High-resolution scanning electron micrographs revealed that CDRs comprise small vertical lamellipodia, the expression pattern of which was disrupted in ARAP1 KO cells. Extracellular solute uptake, rate of cell growth, and malignant potential were attenuated in the KO cells. ARAP1 is also localized in Hep3B cell mitochondria, although not in those of the Huh7 hepatocellular carcinoma cell line. On the basis of these findings, we propose that the aberrant expression of ARAP1 in Hep3B cells modulates CDRs, thereby resulting in an excess uptake of nutrients as an initial event in cancer development.

Cell Biology
PGAM5 regulates DRP1-mediated mitochondrial fission/mitophagy flux in lipid overload-induced renal tubular epithelial cell necroptosis

Dan Sang,Xinyue Duan,Xiaoli Yu,Jiabin Zang,Lan Liu,Guifu Wu

DOI: https://doi.org/10.1016/j.toxlet.2022.10.003

2023-01-01

Abstract:The pathophysiology of renal lipid toxicity caused by excess adiposity is not well-understood. Necroptosis, a regulated form of cell death, is involved in injuring renal tubular epithelial cells (RTECs). Phosphoglycerate mutase 5 (PGAM5) is a key downstream effector of necroptosis. This study investigated the underlying mechanism of PGAM5 in promoting lipid-induced necroptosis in RTECs. HK2 cells (an immortalized proximal tubule epithelial cell line) were exposed to oleic acid (OA) to mimic the lipid overload environment in vitro. We found that OA suppressed HK2 cell proliferation, triggered cytoskeleton rupture and cell death. In OA-treated cells, upregulated expression of necroptosis pathway proteins, phosphorylated receptor-interacting protein-1/3 (pRIPK1/3), phosphorylated mixed lineage kinase domain-like protein (pMLKL), PGAM5, phosphorylated dynamin-related protein 1 (pDRP1S616), and downregulated pDRP1S637 expression were observed. This was accompanied by mitochondrial dysfunction (mitochondrial ROS overproduction and decreased mitochondrial membrane potential) and increased cellular necrosis, as reflected by Annexin V/ Propidium Iodide (PI) labeling. OA also induced the accumulation of LC3II and P62, blocking autophagosome fusion with lysosomes. Knockdown of PGAM5 could prevent these OA-induced changes. We propose inhibition of PGAM5 protects lipid-induced RTECs from necroptosis by reducing DRP1-mediated mitochondrial fission and improving mitophagy flux.
Glyceraldehyde-3-phosphate Dehydrogenase Promotes Liver Tumorigenesis by Modulating Phosphoglycerate Dehydrogenase.

Shanshan Liu,Yu Sun,Ming Jiang,Yangkai Li,Ye Tian,Weili Xue,Ninghe Ding,Yue Sun,Cheng,Jianshuang Li,Xiaoping Miao,Xinran Liu,Ling Zheng,Kun Huang

DOI: https://doi.org/10.1002/hep.29202

IF: 17.298

2017-01-01

Hepatology

Abstract:Up-regulated glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is observed in multiple cancers with unclear mechanism. Using GAPDH transgenic mouse and a mouse model of diethylnitrosamine-induced hepatocellular carcinoma (HCC), here we show that GAPDH overexpression aggravated tumor development by activating cell proliferation and inflammation. In cultured hepatic cells, overexpression of GAPDH or a catalytic domain-deleted GAPDH (GAPDH Delta CD) affected metabolism, up-regulated phosphoglycerate dehydrogenase (PHGDH), increased histone methylation levels, and promoted proliferation. Consistently, inhibition of GAPDH by short hairpin RNA reprogrammed metabolism downregulated PHGDH and histone methylation, and inhibited proliferation. The xenograft study suggested that HepG2 cells overexpressing GAPDH or GAPDH Delta CD similarly promoted tumor development, whereas knockdown PHGDH in GAPDH overexpressing cells significantly inhibited tumor development. In liver sections of HCC patients, increased GAPDH staining was found to be positively correlated with PHGDH and histone methylation staining. Conclusion: GAPDH increases histone methylation levels by up-regulating PHGDH, promoting diversion from glycolysis to serine biosynthesis, and consequently accelerating HCC development.
DRP1 Upregulation Promotes Pancreatic Cancer Growth and Metastasis Through Increased Aerobic Glycolysis

Jing Liang,Yiping Yang,Lu Bai,Feng Li,Enxiao Li

DOI: https://doi.org/10.1111/jgh.14912

2020-01-01

Journal of Gastroenterology and Hepatology

Abstract:Background Mitochondrial shape is dynamically changed by fusion and fission processes in cells, and dysfunction of this process has become one of the emerging hallmarks of cancer. However, the expression patterns and biological effects of mitochondrial fission and fusion proteins in pancreatic cancer (PC) are still unclear. Methods The expressions of mitochondrial fission and fusion proteins were first evaluated by quantitative reverse transcription polymerase chain reaction and western blot analysis in both PC cell lines and tissue samples. In addition, the biologic functions of the differentially expressed proteins in PC cell growth and metastasis both in vitro and in vivo and their potential underlying mechanisms were systematically explored. Results We first found that DRP1 was substantially upregulated in PC cell lines and tissue samples mainly due to the downregulation of miR-29a, which contributed to the poor survival of PC patients. DRP1 promoted the growth and metastasis of PC cells both in vitro and in vivo by inducing G1-S cell cycle transition and matrix metalloproteinase 2 secretion. Mechanistic investigations revealed that increased DRP1 upregulation-mediated mitochondrial fission and subsequently enhanced aerobic glycolysis were involved in the promotion of growth and metastasis by DRP1 in PC cells. Conclusions Our findings demonstrate that mitochondrial fusion protein DRP1 plays a critical oncogenic role in PC cells by enhancing aerobic glycolysis, which could serve as a novel therapeutic target for PC treatment.
Supplementary Figure 2 from Critical Role of 6-Phosphogluconate Dehydrogenase in TAp73-Mediated Cancer Cell Proliferation

Rui Qiao,Mengmeng Wei,Hui Chen,Xianhong Zhang,Jie Zhang,Liyang Gao,Haijun Ma,Yujiong Wang,Le Li

DOI: https://doi.org/10.1158/1541-7786.22743765

2023-01-01

Abstract:S2. TAp73 enhances PPP via 6PGD
PGAM5 is an MFN2 phosphatase that plays an essential role in the regulation of mitochondrial dynamics

Sudeshna Nag,Kaitlin Szederkenyi,Olena Gorbenko,Hannah Tyrrell,Christopher M Yip,G Angus McQuibban,Christopher M. Yip,G. Angus McQuibban

DOI: https://doi.org/10.1016/j.celrep.2023.112895

IF: 8.8

2023-07-27

Cell Reports

Abstract:Nag et al. show that PGAM5 controls mitochondrial morphology by regulating MFN2 function. PGAM5 interacts with MFN2 in a stress-sensitive manner. The PGAM5-MFN2 interaction protects MFN2 from phosphorylation and enhances its stability and fusogenic activity. PGAM5 depletion results in enhanced MFN2 phosphorylation, suggesting its role as a possible MFN2 phosphatase.

cell biology
Phosphoglycerate Mutase 1 Regulates Dntp Pool and Promotes Homologous Recombination Repair in Cancer Cells

Jia Qu,Wenyi Sun,Jie Zhong,Hao Lv,Mingrui Zhu,Jun Xu,Nan Jin,Zuoquan Xie,Minjia Tan,Shu-Hai Lin,Meiyu Geng,Jian Ding,Min Huang

DOI: https://doi.org/10.1083/jcb.201607008

2017-01-01

The Journal of Cell Biology

Abstract:Glycolytic enzymes are known to play pivotal roles in cancer cell survival, yet their molecular mechanisms remain poorly understood. Phosphoglycerate mutase 1 (PGAM1) is an important glycolytic enzyme that coordinates glycolysis, pentose phosphate pathway, and serine biosynthesis in cancer cells. Herein, we report that PGAM1 is required for homologous recombination (HR) repair of DNA double-strand breaks (DSBs) caused by DNA-damaging agents. Mechanistically, PGAM1 facilitates DSB end resection by regulating the stability of CTBP-interacting protein (CtIP). Knockdown of PGAM1 in cancer cells accelerates CtIP degradation through deprivation of the intracellular deoxyribonucleotide triphosphate pool and associated activation of the p53/p73 pathway. Enzymatic inhibition of PGAM1 decreases CtIP protein levels, impairs HR repair, and hence sensitizes BRCA1/2-proficient breast cancer to poly(ADP-ribose) polymerase (PARP) inhibitors. Together, this study identifies a metabolically dependent function of PGAM1 in promoting HR repair and reveals a potential therapeutic opportunity for PGAM1 inhibitors in combination with PARP inhibitors.
DGAT2 Plays a Crucial Role to Control ESRRAPROX1 Transcriptional Network to Maintain Hepatic Mitochondrial Sustainability

Yoseob Lee,Yeseong Hwang,Minki Kim,Hyeonuk Jeon,Seyeon Joo,Sungsoon Fang,Jae-Woo Kim

DOI: https://doi.org/10.4093/dmj.2023.0368

2024-04-24

Diabetes & Metabolism Journal

Abstract:Download PDF Background Diacylglycerol O-acyltransferase 2 (DGAT2) synthesizes triacylglycerol (TG) from diacylglycerol; therefore, DGAT2 is considered as a therapeutic target for steatosis. However, the consequence of inhibiting DGAT2 is not fully investigated due to side effects including lethality and lipotoxicity. In this article, we observed the role of DGAT2 in hepatocarcinoma. Methods The role of DGAT2 is analyzed via loss-of-function assay. DGAT2 knockdown (KD) and inhibitor treatment on HepG2 cell line was analyzed. Cumulative analysis of cell metabolism with bioinformatic data were assessed, and further compared with different cohorts of liver cancer patients and non-alcoholic fatty liver disease (NAFLD) patients to elucidate how DGAT2 is regulating cancer metabolism. Results Mitochondrial function is suppressed in DGAT2 KD HepG2 cell along with the decreased lipid droplets. In the aspect of the cancer, DGAT2 KD upregulates cell proliferation. Analyzing transcriptome of NAFLD and hepatocellular carcinoma (HCC) patients highlights negatively correlating expression patterns of 73 lipid-associated genes including DGAT2. Cancer patients with the lower DGAT2 expression face lower survival rate. DGAT2 KD cell and patients' transcriptome show downregulation in estrogen- related receptor alpha (ESRRA) via integrated system for motif activity response analysis (ISMARA), with increased dimerization with corepressor prospero homeobox 1 (PROX1). Conclusion DGAT2 sustains the stability of mitochondria in hepatoma via suppressing ESRRA-PROX1 transcriptional network and hinders HCC from shifting towards glycolytic metabolism, which lowers cell proliferation.

endocrinology & metabolism

Supplementary Figure S2 from Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis

Supplementary Figure S5 from Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis

Supplementary Figure S3 from Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis

Supplementary Figure S1 from Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis

Supplementary Figure S7 from Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis

Supplementary Figure S4 from Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis

Data from Amplification of Glyceronephosphate O-Acyltransferase and Recruitment of USP30 Stabilize DRP1 to Promote Hepatocarcinogenesis

Amplification of glyceronephosphate O-acyltransferase and recruitment of USP30 stabilize DRP1 to promote hepatocarcinogenesis.

O-GlcNAcylation Promotes Pancreatic Tumor Growth by Regulating Malate Dehydrogenase 1

Stabilization of FASN by ACAT1-mediated GNPAT Acetylation Promotes Lipid Metabolism and Hepatocarcinogenesis

Regulation of mitochondrial fission by GIPC-mediated Drp1 retrograde transport

Figure S7 from P38γ MAPK is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis

O-GlcNAcylation of G6PD Promotes the Pentose Phosphate Pathway and Tumor Growth

GTPase-activating protein ARAP1 regulates circular dorsal ruffles as a nutrient uptake mechanism in the Hep3B hepatocellular carcinoma cell line

PGAM5 regulates DRP1-mediated mitochondrial fission/mitophagy flux in lipid overload-induced renal tubular epithelial cell necroptosis

Glyceraldehyde-3-phosphate Dehydrogenase Promotes Liver Tumorigenesis by Modulating Phosphoglycerate Dehydrogenase.

DRP1 Upregulation Promotes Pancreatic Cancer Growth and Metastasis Through Increased Aerobic Glycolysis

Supplementary Figure 2 from Critical Role of 6-Phosphogluconate Dehydrogenase in TAp73-Mediated Cancer Cell Proliferation

PGAM5 is an MFN2 phosphatase that plays an essential role in the regulation of mitochondrial dynamics

Phosphoglycerate Mutase 1 Regulates Dntp Pool and Promotes Homologous Recombination Repair in Cancer Cells

DGAT2 Plays a Crucial Role to Control ESRRAPROX1 Transcriptional Network to Maintain Hepatic Mitochondrial Sustainability